Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 110 | 97 | 97 | 183 | 86 |
| Gross Profit | 110 | 97 | 97 | 183 | 86 |
| Operating Expenses | 467 | 590 | 562 | 792 | 403 |
| Operating Income | -357 | -493 | -466 | -609 | -318 |
| Interest Expense | -719 | 260 | 205 | 202 | 242 |
| Other Income | 0 | 0 | 0 | 34 | -19 |
| Pre-tax Income | 362 | -752 | -671 | -777 | -579 |
| Income Tax | N/A | -3 | -80 | N/A | N/A |
| Net Income Continuous | 362 | -750 | -591 | -777 | -579 |
| Net Income | $362 | $-750 | $-591 | $-777 | $-579 |
| EPS Basic Total Ops | 0.03 | -0.06 | -0.06 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | 0.03 | -0.06 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Total Ops | 0.03 | -0.06 | -0.06 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | 0.03 | -0.06 | -0.04 | -0.04 | -0.05 |
| EBITDA(a) | $-142 | $-299 | $-311 | $-463 | $-187 |